Neurorehabilitation Devices Market Size, Industry Growth, Trends, Key Players Analysis, Report 2023-2028

According to IMARC Group latest report titled "Neurorehabilitation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on neurorehabilitation devices market. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global neurorehabilitation devices market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2028, exhibiting a growth rate (CAGR) of 10.5% during 2023-2028.

Neurorehabilitation devices are specialized tools and equipment designed to aid in the recovery and rehabilitation of individuals with neurological disorders or injuries. These devices are tailored to address a range of conditions, including stroke, spinal cord injuries, traumatic brain injuries, and neurodegenerative diseases. They assist patients in regaining motor function, improving coordination, and enhancing overall mobility. Neurorehabilitation devices encompass a diverse array of technologies, such as robotic exoskeletons, brain-computer interfaces, functional electrical stimulation devices, and virtual reality platforms. By offering targeted and adaptive interventions, these devices aim to optimize neuroplasticity and facilitate the relearning of motor skills, fostering improved quality of life and functional independence for individuals undergoing neurorehabilitation.

Get a Sample Copy of this Report: https://www.imarcgroup.com/neurorehabilitation-devices-market/requestsample

Market Trends:

The global market is majorly driven by the increasing prevalence of neurological disorders, such as strokes and traumatic brain injuries. As the incidence of these conditions rises, the demand for effective rehabilitation solutions intensifies, driving the adoption of neurorehabilitation devices. Technological advancements play a pivotal role, with continuous innovations in robotics, virtual reality, and neurostimulation techniques enhancing the capabilities of these devices. Besides, the growing awareness of the benefits of early and intensive rehabilitation, coupled with a shift towards patient-centric healthcare, fuels market expansion. Additionally, an ageing population, more prone to neurodegenerative diseases, contributes to the rising need for neurorehabilitation interventions.

The emphasis on personalized medicine and targeted therapies further drives the development and adoption of advanced neurorehabilitation devices, tailoring rehabilitation strategies to individual patient needs. Integration of these devices into rehabilitation centres, hospitals, and home-based care settings broadens their accessibility, promoting overall market growth. The COVID-19 pandemic has also accelerated the acceptance of telehealth and remote monitoring, creating opportunities for neurorehabilitation devices in virtual rehabilitation programs. Furthermore, collaborations between healthcare providers, researchers, and technology developers foster an environment conducive to continuous innovation and expansion of the market. As the healthcare landscape prioritizes functional outcomes and patient well-being, the demand for these devices is poised to accelerate, facilitating enhanced recovery and improved quality of life for neurorehabilitation individuals.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/neurorehabilitation-devices-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

• Biometrics Ltd, Bioness Inc.
• Bionik Laboratories Corp
• BioXtreme Ltd.
• Boston Scientific Corporation
• Ectron Ltd
• Ekso Bionics
• Hocoma AG (DIH International Limited)
• Kinestica
• Kinova Inc.
• Medtronic plc
• Saebo Inc
• Tyromotion GmbH

Neurorehabilitation Devices Market Segmentation:

Our report has categorized the market based on region, product type, application and end use.

Breakup by Product Type:
• Neurorobotic Devices
• Wearable Devices
• Non-Invasive Stimulators
• Brain-Computer Interface

Breakup by Application:
• Stroke
• Multiple Sclerosis
• Parkinson's Disease
• Cerebral Palsy
• Others

Breakup by End User:
• Hospitals and Clinics
• Cognitive Care Centers
• Others

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.